No one can prescribe Schedule 1 drugs. Under federal law, Schedule 1 substances are classified as having high abuse potential and no accepted medical use, which means they cannot be prescribed, dispensed, or administered in a standard clinical setting. This applies to every type of healthcare provider, regardless of their credentials or DEA registration. However, there are limited pathways for researchers, clinical trial investigators, and certain state-licensed professionals to legally handle these substances outside of traditional prescribing.
Why Schedule 1 Drugs Can’t Be Prescribed
The Controlled Substances Act divides drugs into five categories, or “schedules,” based on their potential for abuse and whether they have an accepted medical use. Schedule 1 is the most restrictive tier. Drugs placed here, including heroin, LSD, psilocybin, MDMA, and (currently) marijuana, are considered to have no recognized medical application under federal law. That single classification is what makes prescribing them illegal.
DEA-registered practitioners such as physicians, nurse practitioners, and physician assistants can prescribe drugs from Schedules 2 through 5 as allowed by their DEA registration and state medical license. Schedule 1 is explicitly excluded from that authority. A doctor who wrote a prescription for a Schedule 1 substance would be violating federal law, risking their DEA license and potential criminal charges.
Who Can Legally Handle Schedule 1 Substances
While no one can prescribe these drugs, certain people can legally possess and administer them in tightly controlled circumstances.
Researchers With DEA Registration
Scientists conducting studies with Schedule 1 substances must register with the DEA before handling them. This applies to every researcher unless specifically exempted, and it requires a separate application process from standard practitioner registration. Employees of federal, state, or local government institutions and public universities may be exempt from the application fee, but they still need the registration itself. Law enforcement laboratories that use controlled substances as chemical analysis standards also need annual DEA registration, though they’re exempt from fees.
Clinical Trial Investigators
Physicians can administer Schedule 1 drugs to patients during FDA-approved clinical trials. To do this, they submit an Investigational New Drug (IND) application to the FDA, which requires detailed clinical protocols and evidence that early-phase trials won’t expose participants to unnecessary risk. The physician must be directly overseeing the investigation and personally directing how the drug is administered. The FDA’s internal staff specifically consults on IND applications that involve Schedule 1 substances, adding an extra layer of review. This is the only federal pathway through which a patient might legally receive a Schedule 1 drug from a doctor, and it happens strictly within the structure of a research study, not a prescription.
Medical Marijuana: Recommendations, Not Prescriptions
The legal situation around marijuana creates a lot of confusion on this topic. Dozens of states have legalized medical marijuana, and patients in those states obtain it through a doctor. But what the doctor provides is a recommendation, not a prescription. That distinction is legally critical.
Because marijuana remains a Schedule 1 substance at the federal level, a physician who wrote an actual prescription for it would be aiding and abetting the acquisition of a controlled substance. That could lead to revocation of their DEA license and criminal prosecution. Instead, in states with medical marijuana programs, doctors certify that a patient has a qualifying condition (such as cancer, glaucoma, multiple sclerosis, or HIV/AIDS) and write a recommendation. The patient then uses that recommendation to obtain a state-issued medical marijuana card and purchase the drug from a licensed dispensary. The doctor never prescribes, dispenses, or handles the substance directly.
Oregon’s Psilocybin Program
Oregon created a new legal category in 2020 when voters approved regulated psilocybin services. Under this program, licensed facilitators can supervise adults who consume psilocybin at approved service centers. This isn’t prescribing either. Facilitators don’t need to be doctors. They complete a state-approved training program, pass a regulations exam with a score of at least 75 percent, and obtain a facilitator license from the Oregon Psilocybin Services program. The facilitator’s role is to guide and monitor the experience at a licensed location, not to write prescriptions or practice medicine. Colorado has since established a similar framework.
These state-level programs exist in direct tension with federal law, which still classifies psilocybin as Schedule 1. The federal government has generally not pursued enforcement actions against participants in state-regulated programs, but the legal conflict remains unresolved.
Could Marijuana Move Off Schedule 1?
In May 2024, the Department of Justice published a proposed rule to move marijuana from Schedule 1 to Schedule 3, based on a recommendation from the Department of Health and Human Services that marijuana does have a currently accepted medical use. If finalized, this reclassification would allow DEA-registered practitioners to prescribe marijuana the same way they prescribe other Schedule 3 drugs like testosterone or ketamine. The proposal went through a public comment period and formal rulemaking process, but as of now, marijuana has not been rescheduled and remains Schedule 1 at the federal level.
A similar shift could eventually happen with other Schedule 1 substances. MDMA and psilocybin are both in advanced clinical trials for conditions like PTSD and treatment-resistant depression. If the FDA approves them, they would likely need to be rescheduled before doctors could prescribe them outside of research settings.
The Practical Takeaway
If you’re wondering whether your doctor, psychiatrist, or nurse practitioner can write you a prescription for a Schedule 1 drug, the answer is no. The only legal ways to receive these substances are through an FDA-approved clinical trial, a state medical marijuana recommendation (where available), or a state-regulated program like Oregon’s psilocybin services. Each of these operates through a distinct legal mechanism that deliberately avoids the act of prescribing, because prescribing a Schedule 1 drug is something federal law simply does not permit.